CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | Dahan Michel SVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to buy) | +110,000 | 110,000 | ||
| 2021-02-26 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award | +70,000 | 169,000 | ||
| 2021-02-26 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award · Employee Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2021-02-26 | Cotreau Violetta SVP, Chief Accounting Officer | Grant or award | +26,000 | 38,900 | ||
| 2021-02-26 | Cotreau Violetta SVP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to buy) | +44,200 | 44,200 | ||
| 2021-02-26 | Spellman David A SVP, CFO and Treasurer | Grant or award | +70,000 | 70,000 | ||
| 2021-02-26 | Spellman David A SVP, CFO and Treasurer | Grant or award · Employee Stock Option (Right to buy) | +120,000 | 120,000 | ||
| 2021-02-16 | ZUMWALT LEANNE M Director | Grant or award · Stock Option (Right to buy) | +80,200 | 80,200 | ||
| 2020-06-30 | Spellman David A SVP, CFO and Treasurer | Grant or award · Employee Stock Option (Right to buy) | +280,000 | 280,000 | ||
| 2020-06-08 | Smith Cynthia Director | Sale | −4,567 | $12.10 | $55K | 37,833 |
| 2020-06-08 | GILMAN STEVEN C Director | Sale | −4,567 | $12.08 | $55K | 38,864 |
| 2020-06-08 | GOWEN MAXINE Director | Sale | −4,567 | $12.05 | $55K | 24,133 |
| 2020-06-05 | Smith Cynthia Director | Grant or award | +13,700 | 42,400 | ||
| 2020-06-05 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2020-06-05 | GILMAN STEVEN C Director | Grant or award | +13,700 | 43,431 | ||
| 2020-06-05 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2020-06-05 | GOWEN MAXINE Director | Grant or award | +13,700 | 28,700 | ||
| 2020-06-05 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2020-06-05 | ROGERS MICHAEL W Director | Grant or award | +13,700 | 38,629 | ||
| 2020-06-05 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 |
Page 15 of 21 · 405 trades